The Hippo signalling pathway and its implications in human health and diseases

M Fu, Y Hu, T Lan, KL Guan, T Luo… - Signal transduction and …, 2022 - nature.com
As an evolutionarily conserved signalling network, the Hippo pathway plays a crucial role in
the regulation of numerous biological processes. Thus, substantial efforts have been made …

The Hippo pathway: biology and pathophysiology

S Ma, Z Meng, R Chen, KL Guan - Annual review of …, 2019 - annualreviews.org
The Hippo pathway was initially discovered in Drosophila melanogaster as a key regulator
of tissue growth. It is an evolutionarily conserved signaling cascade regulating numerous …

Stem cell factor SOX2 confers ferroptosis resistance in lung cancer via upregulation of SLC7A11

X Wang, Y Chen, X Wang, H Tian, Y Wang, J **… - Cancer research, 2021 - AACR
Ferroptosis is a lipid peroxidation-dependent cell death caused by metabolic dysfunction.
Ferroptosis-associated enzymes are promising therapeutic targets for cancer treatment …

Hippo pathway in organ size control, tissue homeostasis, and cancer

FX Yu, B Zhao, KL Guan - Cell, 2015 - cell.com
Two decades of studies in multiple model organisms have established the Hippo pathway
as a key regulator of organ size and tissue homeostasis. By inhibiting YAP and TAZ …

Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells

U Testa, G Castelli, E Pelosi - Cancers, 2018 - mdpi.com
Lung cancer causes the largest number of cancer-related deaths in the world. Most (85%) of
lung cancers are classified as non-small-cell lung cancer (NSCLC) and small-cell lung …

YAP aggravates inflammatory bowel disease by regulating M1/M2 macrophage polarization and gut microbial homeostasis

X Zhou, W Li, S Wang, P Zhang, Q Wang, J **ao… - Cell reports, 2019 - cell.com
Inflammation, epithelial cell regeneration, macrophage polarization, and gut microbial
homeostasis are critical for the pathological processes associated with inflammatory bowel …

Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance

Y Jeong, NT Hoang, A Lovejoy, H Stehr, AM Newman… - Cancer discovery, 2017 - AACR
Lung squamous cell carcinoma (LSCC) pathogenesis remains incompletely understood,
and biomarkers predicting treatment response remain lacking. Here, we describe novel …

[HTML][HTML] Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer

X Tong, AS Patel, E Kim, H Li, Y Chen, S Li, S Liu… - Cancer Cell, 2024 - cell.com
Summary KRAS G12C inhibitors (adagrasib and sotorasib) have shown clinical promise in
targeting KRAS G12C-mutated lung cancers; however, most patients eventually develop …

Personalized characterization of diseases using sample-specific networks

X Liu, Y Wang, H Ji, K Aihara, L Chen - Nucleic acids research, 2016 - academic.oup.com
A complex disease generally results not from malfunction of individual molecules but from
dysfunction of the relevant system or network, which dynamically changes with time and …

The Hippo pathway in normal development and cancer

M Maugeri-Saccà, R De Maria - Pharmacology & therapeutics, 2018 - Elsevier
The Hippo pathway is a central regulator of organ size and tissue homeostasis. Hippo
kinases and adaptor proteins mediate the phosphorylation and inactivation of YAP and TAZ …